CanSino Biologics’ Covid-19 vaccine granted patent approval in China
China’s National Intellectual Property Administration has reportedly granted patent approval for a potential Covid-19 Vaccine dubbed Ad5-nCoV, developed by biotech company CanSino Biologics and . Chinese news agency